Showing results (41-50 of 61) with videos related to
Sort By:
Pageof 7
European Journal of Human Genetics : EJHG|September 30, 2010
Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patientsAns M W van den Ouweland, Peter Elfferich, Bernard A Zonnenberg, et al.Medical Physics|December 11, 2013
Quantitative Monte Carlo-based holmium-166 SPECT reconstructionMattijs Elschot, Maarten L J Smits, Johannes F W Nijsen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2015
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trialJohn J Bissler, John Christopher Kingswood, Elżbieta Radzikowska, et al.Cancer Biotherapy & Radiopharmaceuticals|November 16, 2006
Lanthanide-loaded liposomes for multimodality imaging and therapySander W Zielhuis, Jan-Henry Seppenwoolde, Vanessa A P Mateus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2003
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trialMichael A Carducci, Robert J Padley, Jurgen Breul, et al.Plos One|July 30, 2013
Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastasesMaarten L J Smits, Andor F van den Hoven, Charlotte E N M Rosenbaum, et al.Biomaterials|July 28, 2007
Long-term toxicity of holmium-loaded poly(L-lactic acid) microspheres in ratsSander W Zielhuis, J Frank W Nijsen, Jan-Henry Seppenwoolde, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2002
The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with (186)Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases. Placebo Controlled Rhenium StudyShiuw H Han, John M H de Klerk, Suzy Tan, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2014
(⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheresMattijs Elschot, Johannes F W Nijsen, Marnix G E H Lam, et al.The Lancet. Oncology|August 28, 2012
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation studyMaarten L J Smits, Johannes F W Nijsen, Maurice A A J van den Bosch, et al.Pageof 7